Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitaka Inoue

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Blood Advances|September 9, 2021
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational studyAyumu Ito, Nobuaki Nakano, Takashi Tanaka, et al.
Bone Marrow Transplantation|June 11, 2026
Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in JapanAsami Kataoka, Noriyoshi Yoshinaga, Yoshitaka Inoue, et al.
Transplantation and Cellular Therapy|May 28, 2026
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient ageKosuke Takano, Masaharu Tamaki, Yoshitaka Inoue, et al.
Nature Communications|April 8, 2015
Reduced Tyk2 gene expression in β-cells due to natural mutation determines susceptibility to virus-induced diabetesKenichi Izumi, Keiichiro Mine, Yoshitaka Inoue, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Blood Advances|September 9, 2021
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational studyAyumu Ito, Nobuaki Nakano, Takashi Tanaka, et al.
Bone Marrow Transplantation|June 11, 2026
Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in JapanAsami Kataoka, Noriyoshi Yoshinaga, Yoshitaka Inoue, et al.
Transplantation and Cellular Therapy|May 28, 2026
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient ageKosuke Takano, Masaharu Tamaki, Yoshitaka Inoue, et al.
Nature Communications|April 8, 2015
Reduced Tyk2 gene expression in β-cells due to natural mutation determines susceptibility to virus-induced diabetesKenichi Izumi, Keiichiro Mine, Yoshitaka Inoue, et al.
Pageof 7